Amino Acid Disorders 1
The Amino Acid Disorders 1 session will be discussing Urea Cycle Disorders, MSUD.
This educational activity is supported by an educational grant from Ultragenyx.
At the conclusion of this session, learners should be able to:
- Comprehend the fundamental clinical and biochemical characteristics of urea cycle disorders.
- Differentiate and recognize the distinct clinical and biochemical features of each urea cycle disorder.
- Develop an understanding of the overall principles for managing urea cycle disorders.
- Understand the clinical and biochemical attributes specific to maple syrup urine disease (MSUD).
- Comprehend the management principles applied in cases of maple syrup urine disease (MSUD).
Children's National Hospital
Nicholas Ah Mew, MD, speaker for this activity, is a consultant for Satellite Bio, Moderna Therapeutics, Jnana Therapeutics and Ultragenyx and a clinical trial principal investigator for Aeglea Biotherapeutics, Hemoshear Therapeutics and Recordati Rare Disease.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance